Understanding the pathophysiology of disease is essential for the development of novel therapeutics. Due to the complexity of biological interactions investigating the biological process in vivo in the mammalian system are required. Techniques of biomedical imaging can be used to probe morphological, physiological and biochemical processes in living systems. The biomedical group comprises a number of state-of-the-art technologies including:
- Magnetic resonance imaging (MRI)
- Computer Tomography (microCT)
- Ultrasound
- Positron Emission Tomography (PET)
- Optical Imaging (bioluminescence and fluorescence).
Success requires a multidisciplinary approach to scientific research and the group includes researchers with expertise in, for example: physiology, engineering, physics, image analysis and data processing, mathematics and synthetic chemistry. Despite the diverse background and training we share a common passion and drive namely, developing non-invasive imaging techniques to enhance our understanding of disease and mechanism of drug action to advance drug discovery and development.